[retrieved on 2014-06-13], PETRINE WELLENDORPH ET AL: "Phenylacetic acids and the structurally related non-steroidal anti-inflammatory drug diclofenac bind to specific [gamma]-hydroxybutyric acid sites in rat brain", FUNDAMENTAL & CLINICAL PHARMACOLOGY, vol.23, no.2, 1 April 2009 (2009-04-01), pages 207-213, XP055123069, ISSN: 0767-3981, DOI:

10.1111/j.1472-8206.2008.00664.x, BHATTACHARYA I ET AL: "GHB (GAMMA-HYDROXYBUTYRATE) CARRIER-MEDIATED TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol.311, no.1, 1 October 2004 (2004-10-01), pages 92-98, XP009049440, ISSN: 0022-3565, DOI: 10.1124/JPET.104.069682, Viviane Hechler ET AL: "gamma-Hydroxybutyrate Conversion into GABA Induces Displacement of GABA B Binding that is Blocked by Valproate and Ethosuximide 1", , 30 January 1997 (1997-01-30), XP055123267, Retrieved from the Internet: URL:http://jpet.aspetjournals.org/content/ 281/2/753.full.pdf#page=1&view=FitH [retrieved on 2014-06-13]

Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/